Cena / účetní hodnota společnosti Acasti Pharma Inc

Jaká je hodnota metriky Cena / účetní hodnota společnosti Acasti Pharma Inc?

Hodnota metriky Cena / účetní hodnota společnosti Acasti Pharma Inc je 0.13

Jaká je definice metriky Cena / účetní hodnota?



Cena / učetní hodnota (Price to book ratio) je ukazatel, který vyjadřuje poměr mezi hodnotou společnosti a book value společnosti, což je hodnota čistých aktiv.

The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).

The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).

P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.

Cena / účetní hodnota společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Acasti Pharma Inc

Čemu se věnuje společnost Acasti Pharma Inc?

acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.

Firmy s metrikou cena / účetní hodnota podobnou společnosti Acasti Pharma Inc



  • Hodnota metriky Cena / účetní hodnota společnosti Brighthouse je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Kirloskar Electric je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Educomp Solutions je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Plastiques du Val de Loire je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Hang Lung je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Polo Resources je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Acasti Pharma Inc je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Value8 N.V je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti SandRidge Permian Trust je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Ulta Beauty je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Avaya je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Century Ginwa Retail je 0.13
  • Hodnota metriky Cena / účetní hodnota společnosti Ever-Glory International je 0.13